Life Science Compliance Update

November

2017

The Expanding Frontier Part 2 – Navigating the Complexity of Patient Advocacy Groups

Written by , Posted in Uncategorized

Chad A. Morin, Senior Director Healthcare Compliance, bluebird bio

Although many Patient Advocacy Groups have been around for more than 20 years, it has only been in the past couple years that they have had a substantial impact. It is clear that engaging with and assisting PAGs can provide a shared-value to patients. However, doing so is not a simple matter, and this article explores some of the many factors that companies should consider.


   or   


Menu Title